Sonendo (SONX) Competitors

Heart Test Laboratories (NASDAQ:HSCS) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, community ranking, valuation and profitability.

Which has better valuation & earnings, HSCS or SONX?

Heart Test Laboratories has higher earnings, but lower revenue than Sonendo. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heart Test Laboratories	$14.70K	209.66	-$6.61M	-$7.48	-0.38
Sonendo	$44.40M	0.02	-$60.92M	-$69.77	-0.02

Does the media favor HSCS or SONX?

In the previous week, Heart Test Laboratories had 3 more articles in the media than Sonendo. MarketBeat recorded 4 mentions for Heart Test Laboratories and 1 mentions for Sonendo. Heart Test Laboratories' average media sentiment score of 0.98 beat Sonendo's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Heart Test Laboratories	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community believe in HSCS or SONX?

Sonendo received 5 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 85.71% of users gave Heart Test Laboratories an outperform vote while only 40.74% of users gave Sonendo an outperform vote.

Company	Underperform	Outperform
Heart Test Laboratories	Outperform Votes 6 85.71%	Underperform Votes 1 14.29%
Sonendo	Outperform Votes 11 40.74%	Underperform Votes 16 59.26%

Which has more volatility and risk, HSCS or SONX?

Heart Test Laboratories has a beta of 2.77, suggesting that its share price is 177% more volatile than the S&P 500. Comparatively, Sonendo has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500.

Do analysts rate HSCS or SONX?

Heart Test Laboratories currently has a consensus price target of $13.00, suggesting a potential upside of 355.98%. Given Heart Test Laboratories' stronger consensus rating and higher probable upside, research analysts clearly believe Heart Test Laboratories is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heart Test Laboratories	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals and insiders hold more shares of HSCS or SONX?

17.2% of Heart Test Laboratories shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by company insiders. Comparatively, 7.9% of Sonendo shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Is HSCS or SONX more profitable?

Heart Test Laboratories has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Heart Test Laboratories' return on equity of -117.76% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heart Test Laboratories	N/A	-117.76%	-84.09%
Sonendo	-92.74%	-184.01%	-68.60%

Summary

Heart Test Laboratories beats Sonendo on 12 of the 18 factors compared between the two stocks.